Failure of endophthalmitis prophylaxis: laboratory model comparing antibiotics and bacterial loads. [PDF]
Moon M +4 more
europepmc +1 more source
Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant <i>Escherichia coli</i> using a hollow fiber infection model: a proof-of-concept study. [PDF]
Walker MM +8 more
europepmc +1 more source
PK/PD-guided ceftazidime-avibactam dosing for multidrug-resistant <i>Pseudomonas aeruginosa</i> infection in a preterm infant with chylothorax and ascites: a case report. [PDF]
Yuan W, Zhao X, Liu X, Tao X, Zeng L.
europepmc +1 more source
<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]
Yanagihara K +7 more
europepmc +1 more source
Combination Therapy with Ceftazidime-Avibactam, Aztreonam, and Topical Polymyxin B for NDM-Producing <i>Klebsiella pneumoniae</i> CNS Infection: A Case Report. [PDF]
Qi G +6 more
europepmc +1 more source
Disease severity modifies the ceftazidime-avibactam exposure-response relationship in critically ill patients: a retrospective study. [PDF]
Qian S, Xu D, Xu Y, Qi H, Liang P.
europepmc +1 more source
Mutational basis of ceftazidime-borrelidin A collateral sensitivity in Escherichia coli. [PDF]
Phillips LL +5 more
europepmc +1 more source
Likelihood of aggressive PK/PD target attainment of continuous-infusion beta-lactams during the first week of treatment of febrile neutropenia: findings from a 1-year prospective, monocentric study in onco-haematological patients. [PDF]
Cojutti PG +9 more
europepmc +1 more source
Melioidosis Presenting as a Mycotic Aneurysm of the Aortic Arch in a Patient With Pyrexia of Unknown Origin: A Case Report. [PDF]
Fenn BN +4 more
europepmc +1 more source

